VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,901 | +901.3% | 157,153 | +1427.4% | 0.00% | – |
| Q2 2023 | $67,804 | -77.1% | 10,289 | -74.3% | 0.00% | -100.0% |
| Q4 2022 | $296,250 | +196.2% | 40,088 | +296.2% | 0.00% | – |
| Q3 2022 | $100,000 | -64.9% | 10,118 | -49.9% | 0.00% | -100.0% |
| Q2 2019 | $285,000 | -31.3% | 20,197 | -18.0% | 0.00% | 0.0% |
| Q1 2018 | $415,000 | +159.4% | 24,617 | +134.4% | 0.00% | – |
| Q4 2017 | $160,000 | -59.2% | 10,500 | -52.1% | 0.00% | -100.0% |
| Q3 2017 | $392,000 | +83.2% | 21,900 | -14.5% | 0.00% | +100.0% |
| Q1 2016 | $214,000 | -40.2% | 25,600 | -33.4% | 0.00% | -50.0% |
| Q4 2015 | $358,000 | -4.3% | 38,460 | +15.8% | 0.00% | -33.3% |
| Q3 2015 | $374,000 | +165.2% | 33,200 | +199.1% | 0.00% | +200.0% |
| Q2 2015 | $141,000 | -96.2% | 11,100 | -95.1% | 0.00% | -97.6% |
| Q1 2014 | $3,664,000 | +332.1% | 225,480 | +114.7% | 0.04% | +200.0% |
| Q2 2013 | $848,000 | – | 105,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |